CN Bio is a close-knit team of passionate scientist working towards a future where drugs are discovered more quickly, brought to patients more cost-effectively, and through the use of less animal experimentation.
HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.
ICON is a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients - reducing time to market, reducing cost and increasing quality.
Lide Biotech is committed to engaging in translational medicine and precision medical research to help guide clinical research and optimize therapeutics for patients around the world, expanding the availability of precision treatment options.
Everyone at AnaBios shares a passion and commitment to make a difference in the development of promising new therapies and cures for patients by reducing the time and expense related to clinical trial failures.